Live
ePaper
Search
Home > India > BRIEF-IMPACT Therapeutics Says EC Approves Senaparib For Advanced Ovarian Cancer Treatment

BRIEF-IMPACT Therapeutics Says EC Approves Senaparib For Advanced Ovarian Cancer Treatment

Written By:
Last Updated: November 17, 2026 06:46:07 IST

Nov 17 (Reuters) – IMPACT Therapeutics, Inc: * EUROPEAN COMMISSION APPROVES SENAPARIB FOR MAINTENANCE TREATMENT OF ADVANCED OVARIAN CANCER Further company coverage:

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

MORE NEWS

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?